Vitamin B12 injection therapy aims to support the bodys natural nerve repair processes, improve comfort in the feet, and assist with overall mobility
What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
Many formulas include vitamin B12 plus compounds like methionine, inositol, and choline (often called MIC)
Full transparency with your prescribing physician is important for safe care
The Phase 2 trial results Published in the New England Journal of Medicine, the Phase 2 trial showed that participants receiving the highest dose of retatrutide (12mg weekly) achieved a mean weight reduction of 24.2% at 48 weeks